Analystreport

Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com